|
1
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hussain SP and Harris CC: Inflammation and
cancer: An ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hugo HJ, Saunders C, Ramsay RG and
Thompson EW: New insights on COX-2 in chronic inflammation driving
breast cancer growth and metastasis. J Mammary Gland Biol
Neoplasia. 20:109–119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harris RE, Casto BC and Harris ZM:
Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J
Clin Oncol. 5:677–692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu H, Ouyang W and Huang C: Inflammation,
a key event in cancer development. Mol Cancer Res. 4:221–233. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Apte RN, Dotan S, Elkabets M, White MR,
Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y and Voronov E: The
involvement of IL-1 in tumorigenesis, tumor invasiveness,
metastasis and tumor-host interactions. Cancer Metastasis Rev.
25:387–408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Apte RN, Krelin Y, Song X, Dotan S, Recih
E, Elkabets M, Carmi Y, Dvorkin T, White RM, Gayvoronsky L, et al:
Effects of micro-environment- and malignant cell-derived
interleukin-1 in carcinogenesis, tumour invasiveness and
tumour-host interactions. Eur J Cancer. 42:751–759. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Voronov E, Shouval DS, Krelin Y, Cagnano
E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN: IL-1 is
required for tumor invasiveness and angiogenesis. Proc Natl Acad
Sci USA. 100:2645–2650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Voronov E, Carmi Y and Apte RN: Role of
IL-1-mediated inflammation in tumor angiogenesis. Adv Exp Med Biol.
601:265–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tu S, Bhagat G, Cui G, Takaishi S,
KurtJones EA, Rickman B, Betz KS, PenzOesterreicher M, Bjorkdahl O,
Fox JG and Wang TC: Overexpression of interleukin-1beta induces
gastric inflammation and cancer and mobilizes myeloid-derived
suppressor cells in mice. Cancer Cell. 14:408–419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weber A, Wasiliew P and Kracht M:
Interleukin-1 (IL-1) pathway. Sci Signal. 3:cm12010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yokoo T and Kitamura M: Dual regulation of
IL-1 beta-mediated matrix metalloproteinase-9 expression in
mesangial cells by NF-kappa B and AP-1. Am J Physiol.
270:F123–F130. 1996.PubMed/NCBI
|
|
14
|
Amin AR Ruhul, Senga T, Oo ML, Thant AA
and Hamaguchi M: Secretion of matrix metalloproteinase-9 by the
proinflammatory cytokine, IL-1beta: A role for the dual signalling
pathways, Akt and Erk. Genes Cells. 8:515–523. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bauvois B: New factors of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
16
|
Ren F, Tang R, Zhang X, Madushi WM, Luo D,
Dang Y, Li Z, Wei K and Chen G: Overexpression of MMP family
members function as prognostic biomarker for breast cancer
patients: A systemic review and meta-analysis. PLoS One.
10:e01355442015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Playford MP and Schaller MD: The interplay
between Src and integrins in normal and tumor biology. Oncogene.
23:7928–7946. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roskoski R Jr: Src kinase regulation by
phosphorylation and dephosphorylation. Biochem Biophys Res Commun.
331:1–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mitra SK and Schlaepfer DD:
Integrin-regulated FAK-Src signaling in normal and cancer cells.
Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hall JE, Fu W and Schaller MD: Focal
adhesion kinase: Exploring FAK structure to gain insight into
function. Int Rev Cell Mol Biol. 228:185–225. 2011. View Article : Google Scholar
|
|
21
|
Calalb MB, Polte TR and Hanks SK: Tyrosine
phosphorylation of focal adhesion kinase at sites in the catalytic
domain regulates kinase activity: A role for Src family kinases.
Mol Cell Biol. 15:954–963. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schlaepfer DD and Hunter T: Evidence for
in vivo phosphorylation of the Grb2 SH2-domain binding site on
focal adhesion kinase by Src-family protein-tyrosine kinases. Mol
Cell Biol. 16:5623–5633. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rahman MA, Senga T, Ito S, Hyodo T,
Hasegawa H and Hamaguchi M: S-nitrosylation at Cystein 498 of c-Src
tyrosine kinase regulates nitoric oxide-mediated cell invasion. J
Biol Chem. 285:3806–3814. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ilić D, Furuta Y, Kanazawa S, Takeda N,
Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M and Yamamoto T:
Reduced cell motility and enhanced focal adhesion contact formation
in cells from FAK-deficient mice. Nature. 377:539–544. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mon NN, Hasegawa H, Thant AA, Huang P,
Tanimura Y, Senga T and Hamaguchi M: A role for focal adhesion
kinase signaling in tumor necrosis factor-alpha-dependent matrix
metalloproteinase-9 production in a cholangiocarcinoma cell line,
CCKS1. Cancer Res. 66:6778–6784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shibata K, Kikkawa F, Nawa A, Thant AA,
Naruse K, Mizutani S and Hamaguchi M: Both focal adhesion kinase
and c-Ras are required for the enhanced matrix metalloproteinase 9
secretion by fibronectin in ovarian cancer cells. Cancer Res.
58:900–903. 1998.PubMed/NCBI
|
|
27
|
Rajshankar D, Downey GP and McCulloch CA:
IL-1β enhances cell adhesion to degraded fibronectin. FASEB J.
26:4429–4444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frame MC: Src in cancer: Deregulation and
consequences for cell behavior. Biochim Biophy Acta. 1602:114–130.
2002.
|
|
29
|
Avizienyte E and Frame MC: Src and FAK
signalling controls adhesion fate and the epithelial-to-mesenchymal
transition. Curr Opin Cell Biol. 17:542–547. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sen T, Dutta A, Maity G and Chatterjee A:
Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human
laryngeal carcinoma cells by involving multiple signaling pathways.
Biochimie. 92:1422–1434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Siesser PM and Hanks SK: The signaling and
biological implications of FAK overexpression in cancer. Clin
Cancer Res. 12:3233–3237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Summy JM and Gallick GE: Src family
kinases in tumor progression and metastasis. Cancer Metastasis Rev.
22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mon NN, Ito S, Senga T and Hamaguchi M:
FAK signaling in neoplastic disorders: A linkage between
inflammation and cancer. Ann NY Acad Sci. 1086:199–212. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Irby RB, Mao W, Coppola D, Kang J, Loubeau
JM, Trudeau W, Karl R, Fujita DJ, Jove R and Yeatman TJ: Activating
SRC mutation in a subset of advanced human colon cancers. Nature
Genet. 21:187–190. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer - a new therapeutic opportunity. Nat Rev Cancer.
5:505–515. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brunton VG and Frame MC: Src and focal
adhesion kinase as therapeutic targets in cancer. Curr Opin
Pharmacol. 8:427–432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoon H, Dehart JP, Murphy JM and Lim ST:
Understanding the role of FAK in cancer: Inhibitors, genetic
models, and new insights. J Histochem Cytochem. 62:114–128. 2015.
View Article : Google Scholar
|
